These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25330392)

  • 1. Contact between doctors and the pharmaceutical industry, their perceptions, and the effects on prescribing habits.
    Lieb K; Scheurich A
    PLoS One; 2014; 9(10):e110130. PubMed ID: 25330392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A survey of german physicians in private practice about contacts with pharmaceutical sales representatives.
    Lieb K; Brandtönies S
    Dtsch Arztebl Int; 2010 Jun; 107(22):392-8. PubMed ID: 20574555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
    Fickweiler F; Fickweiler W; Urbach E
    BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia.
    Wood SF; Podrasky J; McMonagle MA; Raveendran J; Bysshe T; Hogenmiller A; Fugh-Berman A
    PLoS One; 2017; 12(10):e0186060. PubMed ID: 29069085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications.
    Fadare JO; Oshikoya KA; Ogunleye OO; Desalu OO; Ferrario A; Enwere OO; Adeoti A; Sunmonu TA; Massele A; Baker A; Godman B
    Hosp Pract (1995); 2018 Apr; 46(2):77-87. PubMed ID: 29426263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polish physicians' cooperation with the pharmaceutical industry and its potential impact on public health.
    Makowska M
    PLoS One; 2017; 12(9):e0184862. PubMed ID: 28926592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of services provided by pharmaceutical companies: perceptions of physicians and pharmaceutical sales representatives.
    Gaedeke RM; Tootelian DH; Sanders EE
    Health Mark Q; 1999; 17(1):23-31. PubMed ID: 11066720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Japanese practicing physicians' relationships with pharmaceutical representatives: a national survey.
    Saito S; Mukohara K; Bito S
    PLoS One; 2010 Aug; 5(8):e12193. PubMed ID: 20730093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships of physicians with pharmaceutical sales representatives and pharmaceutical companies: an exploratory study.
    Anadaleeb SS; Tallman RF
    Health Mark Q; 1996; 13(4):79-89. PubMed ID: 10159647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Generic drugs: good or bad? Physician's knowledge of generic drugs and prescribing habits].
    García AJ; Martos F; Leiva F; Sánchez de la Cuesta F
    Gac Sanit; 2003; 17(2):144-9. PubMed ID: 12729542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.
    Kersnik J; Peklar J
    J Clin Pharm Ther; 2006 Dec; 31(6):577-83. PubMed ID: 17176362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of pharmaceutical promotion on prescribers in Jordan.
    Altawalbeh SM; Ibrahim IA; Al-Shatnawi SF
    Int J Clin Pharm; 2020 Apr; 42(2):744-755. PubMed ID: 32140917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sources of drug information and their influence on the prescribing behaviour of doctors in a teaching hospital in Ibadan, Nigeria.
    Oshikoya KA; Oreagba I; Adeyemi O
    Pan Afr Med J; 2011; 9():13. PubMed ID: 22145057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What do Libyan doctors perceive as the benefits, ethical issues and influences of their interactions with pharmaceutical company representatives?
    Alssageer MA; Kowalski SR
    Pan Afr Med J; 2013; 14():132. PubMed ID: 23734277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.
    Goupil B; Balusson F; Naudet F; Esvan M; Bastian B; Chapron A; Frouard P
    BMJ; 2019 Nov; 367():l6015. PubMed ID: 31690553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey.
    Watkins C; Harvey I; Carthy P; Moore L; Robinson E; Brawn R
    Qual Saf Health Care; 2003 Feb; 12(1):29-34. PubMed ID: 12571342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doctors' Interactions with Pharmaceutical Sales Representatives: Modelling Doctors Prescription Behaviour.
    Faisal A; Ahmad MS; Thurasamy R; Ahmed R
    Community Ment Health J; 2020 Apr; 56(3):456-463. PubMed ID: 31728716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru.
    De Ferrari A; Gentille C; Davalos L; Huayanay L; Malaga G
    PLoS One; 2014; 9(6):e100114. PubMed ID: 24978481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is it pertinent to investigate the relations between physicians and the drug industry].
    Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
    Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.